ATE230413T1 - Pharmazeutisch verträgliche salze von 3-hydroxy- estr-5(10)-en-17-on-3-sulfat die als östrogene aktiv sind - Google Patents

Pharmazeutisch verträgliche salze von 3-hydroxy- estr-5(10)-en-17-on-3-sulfat die als östrogene aktiv sind

Info

Publication number
ATE230413T1
ATE230413T1 AT98918801T AT98918801T ATE230413T1 AT E230413 T1 ATE230413 T1 AT E230413T1 AT 98918801 T AT98918801 T AT 98918801T AT 98918801 T AT98918801 T AT 98918801T AT E230413 T1 ATE230413 T1 AT E230413T1
Authority
AT
Austria
Prior art keywords
estr
estrogens
hydroxy
sulfate
active
Prior art date
Application number
AT98918801T
Other languages
English (en)
Inventor
Michael Z Kagan
Fangming Kong
Leonard Alexander Mcdonald
Panolil Raveendranath
Syed Muzafar Shah
Joseph Zeldis
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of ATE230413T1 publication Critical patent/ATE230413T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT98918801T 1997-05-02 1998-04-28 Pharmazeutisch verträgliche salze von 3-hydroxy- estr-5(10)-en-17-on-3-sulfat die als östrogene aktiv sind ATE230413T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85056897A 1997-05-02 1997-05-02
PCT/US1998/008481 WO1998050413A1 (en) 1997-05-02 1998-04-28 Pharmaceutically acceptable salts of 3-hydroxy-estr-5(10)-en-17-one 3-sulphate active as estrogens

Publications (1)

Publication Number Publication Date
ATE230413T1 true ATE230413T1 (de) 2003-01-15

Family

ID=25308509

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98918801T ATE230413T1 (de) 1997-05-02 1998-04-28 Pharmazeutisch verträgliche salze von 3-hydroxy- estr-5(10)-en-17-on-3-sulfat die als östrogene aktiv sind

Country Status (14)

Country Link
EP (1) EP0980383B1 (de)
JP (1) JP2001523266A (de)
KR (1) KR20010012193A (de)
CN (1) CN1254341A (de)
AR (1) AR015375A1 (de)
AT (1) ATE230413T1 (de)
AU (1) AU730300B2 (de)
BR (1) BR9809437A (de)
CA (1) CA2289008A1 (de)
DE (1) DE69810461T2 (de)
DK (1) DK0980383T3 (de)
ES (1) ES2187963T3 (de)
WO (1) WO1998050413A1 (de)
ZA (1) ZA983698B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002338277B2 (en) * 2001-03-16 2007-11-22 Wyeth Estrogen replacement therapy

Also Published As

Publication number Publication date
AU7165598A (en) 1998-11-27
AU730300B2 (en) 2001-03-01
BR9809437A (pt) 2000-06-13
DE69810461T2 (de) 2003-10-02
CA2289008A1 (en) 1998-11-12
HK1025336A1 (en) 2000-11-10
CN1254341A (zh) 2000-05-24
ES2187963T3 (es) 2003-06-16
KR20010012193A (ko) 2001-02-15
DE69810461D1 (de) 2003-02-06
DK0980383T3 (da) 2003-04-14
ZA983698B (en) 1999-11-01
EP0980383A1 (de) 2000-02-23
JP2001523266A (ja) 2001-11-20
EP0980383B1 (de) 2003-01-02
WO1998050413A1 (en) 1998-11-12
AR015375A1 (es) 2001-05-02

Similar Documents

Publication Publication Date Title
FI952033L (fi) Farmakologisesti aktiiviset pyrrolopyrimidiinijohdannaiset
KR970006279A (ko) 약제학적 활성 성분으로서의 6-디메틸아미노메틸-1-페닐-사이클로헥산 화합물
FI973518L (fi) Farmaseuttinen koostumus piperidinoalkanoliyhdisteille
IS4715A (is) Lyfjafræðilega virk kínasólín efnasambönd
DE69619220D1 (de) Manipulaton von grafikbildern
PT892640E (pt) Composicoes farmaceuticas de micofenolato entericamente revestidas
FI971018L (fi) Farmaseuttisia yhdisteitä
NO962606D0 (no) Farmasöytisk sammensetning
NO995533D0 (no) Ny fremgangsmåte for fremstilling av en farmakologisk aktiv substans
NO980240D0 (no) Paroxetin-kontrollert frigjörings-blandinger
BR9610396A (pt) Formulação farmacêutica
NO980546D0 (no) Farmasöytiske midler
FI954243A7 (fi) Farmaseuttiset yhdisteet
DE69618940D1 (de) Tensidzusammensetzungen
ATA181095A (de) Probiotisch wirksame formulierung
IT1276799B1 (it) Formulazioni di f-silicone
ID24270A (id) Penghilang sumbatan keratotik
FI973229L (fi) Uusi farmaseuttinen koostumus
DE69528843D1 (de) Pharmakologisch aktive 2-mercaptobenzimidazolderivate
DE59308091D1 (de) Alkenylbernsteinsäurederivate als Metallbearbeitungshilfsmittel
ID23437A (id) Penghilang sumbatan keratotik
FI973280L (fi) Farmaseuttinen koostumus
NO994049D0 (no) Metode for å fremstille farmasöytiske forbindelser
FI973230L (fi) Uusi farmaseuttinen formulaatio
DE69810461D1 (de) Pharmazeutisch verträgliche salze von 3-hydroxy-estr-5(10)-en-17-on-3-sulfat die als östrogene aktiv sind

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0980383

Country of ref document: EP

REN Ceased due to non-payment of the annual fee